Wall Street analysts forecast that Intuitive Surgical, Inc. (NASDAQ:ISRG) will post $752.33 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Intuitive Surgical’s earnings. The lowest sales estimate is $744.00 million and the highest is $759.10 million. Intuitive Surgical posted sales of $682.90 million during the same quarter last year, which suggests a positive year over year growth rate of 10.2%. The company is expected to issue its next quarterly earnings report on Tuesday, October 17th.
On average, analysts expect that Intuitive Surgical will report full year sales of $752.33 million for the current year, with estimates ranging from $2.89 billion to $3.05 billion. For the next fiscal year, analysts expect that the business will report sales of $3.37 billion per share, with estimates ranging from $3.20 billion to $3.49 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Intuitive Surgical.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The firm had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.62 earnings per share.
Several research analysts have commented on the stock. Canaccord Genuity reissued a “hold” rating and set a $1,000.00 price objective (up previously from $870.00) on shares of Intuitive Surgical in a report on Wednesday, July 26th. BidaskClub downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Barclays PLC increased their price target on shares of Intuitive Surgical from $870.00 to $1,000.00 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Morgan Stanley reaffirmed an “overweight” rating and issued a $1,070.00 price target (up previously from $950.00) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $1,067.00 price target for the company in a report on Tuesday, July 25th. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical has an average rating of “Buy” and an average target price of $980.03.
Intuitive Surgical (NASDAQ:ISRG) traded down 0.33% on Thursday, hitting $931.07. The stock had a trading volume of 324,899 shares. The company’s 50 day moving average price is $939.10 and its 200 day moving average price is $821.45. The firm has a market cap of $34.59 billion, a price-to-earnings ratio of 44.60 and a beta of 0.39. Intuitive Surgical has a 52-week low of $610.71 and a 52-week high of $974.66.
In related news, VP Jamie Samath sold 1,946 shares of the stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $921.26, for a total value of $1,792,771.96. Following the sale, the vice president now directly owns 130 shares of the company’s stock, valued at approximately $119,763.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 17,975 shares of the stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the completion of the sale, the chief executive officer now directly owns 101,798 shares in the company, valued at $95,412,211.46. The disclosure for this sale can be found here. Insiders sold a total of 34,065 shares of company stock worth $31,659,090 over the last three months. 2.50% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of ISRG. Alps Advisors Inc. raised its position in shares of Intuitive Surgical by 0.3% in the second quarter. Alps Advisors Inc. now owns 647 shares of the medical equipment provider’s stock worth $605,000 after buying an additional 2 shares during the period. Guardian Life Insurance Co. of America raised its position in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the period. Greenleaf Trust raised its position in shares of Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock worth $366,000 after buying an additional 4 shares during the period. Dynamic Advisors Solutions LLC raised its position in shares of Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock worth $694,000 after buying an additional 5 shares during the period. Finally, Bronfman E.L. Rothschild L.P. raised its position in shares of Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock worth $215,000 after buying an additional 5 shares during the period. 96.71% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
